12 citations
,
March 2022 in “Frontiers in Nutrition”
This review discusses the complex skin changes associated with obesity and the potential benefits of nutritional interventions for inflammatory skin diseases, without reporting new clinical results.
78 citations
,
January 2000 in “Gynecological Endocrinology”
This study found that the progestins norgestimate and dienogest may help treat clinical hyperandrogeny in women by inhibiting skin 5 alpha-reductase activity with minimal androgenic potential.
This article reviews the role of androgens in skin metabolism and diseases like acne and androgenic alopecia, but reports no new clinical results; the authors note unresolved issues regarding androgen interactions in skin structures.
January 1990 in “Journal of dermatological treatment”
This study found no significant relationship between clinical markers of hyperandrogenism and lack of response to conventional antibiotic therapy in women with acne.
The conversation discusses hair loss treatments, primarily finasteride, and the effects of shedding, miniaturization, and regrowth. Users share experiences with finasteride, minoxidil, and dutasteride, noting normal shedding patterns and potential regrowth signs like baby hairs.
Dutasteride significantly improved hair health and reduced shedding for a woman with PCOS and hyperandrogenism, without causing depression or anxiety, unlike finasteride. Dutasteride also helped with PMDD symptoms and had no side effects, though it changed hair texture.
Dihydrotestosterone (DHT) impacts various skinconditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.